| Literature DB >> 33344937 |
Paul Carragher1, Alan Rankin2,3, Pascal Edouard4,5,6,7,8.
Abstract
Background: In high-level adult athletes, injury incidences and characteristics have been reported during international championships and during one season. Youth track and field athletes are also exposed to injury risk, although less information is available on this specific population, as well as on illness risk. Aim: To determine the prevalence of health problems (i.e., illnesses, acute, and overuse injuries) in high level Youth and Junior Track & Field athletes. Method: During the 2015-16 athletics season (30 weeks from December 2015 to July 2016), we conducted a prospective cohort study on a population of Youth and Junior Irish national level athletes, during which athletes were asked to complete a weekly web-based questionnaire (Oslo Sports Trauma Research Center questionnaire on health problems) regarding their health problems.Entities:
Keywords: epidemiology; health protection; sports injury prevention; top-level athletes; track and field
Year: 2019 PMID: 33344937 PMCID: PMC7739821 DOI: 10.3389/fspor.2019.00013
Source DB: PubMed Journal: Front Sports Act Living ISSN: 2624-9367
Number (percentage) of athletes included in the study, and number (percentage) of athletes presenting at least one health problem during the 30-week study period according to sex and discipline groups.
| n (% of all athletes) | 70 | (100.0) | 25 | (35.7) | 45 | (64.3) | 37 | (52.9) | 19 | (27.1) | 18 | (25.7) | 33 | (47.1) | 6 | (8.6) | 27 | (38.6) |
| Age (mean (SD)) | 17.1 | (0.8) | 17.3 | (0.7) | 16.9 | (0.9) | 17.2 | (0.8) | 17.3 | (0.7) | 17.1 | (0.9) | 16.9 | (0.8) | 17.3 | (0.5) | 16.8 | (0.9) |
| All health problems | 61 | (87.1) | 18 | (72.0) | 43 | (95.6) | 30 | (81.1) | 13 | (68.4) | 17 | (94.4) | 31 | (93.9) | 5 | (83.3) | 26 | (96.3) |
| Illness | 42 | (60.0) | 11 | (44.0) | 31 | (68.9) | 18 | (48.6) | 8 | (42.1) | 10 | (55.6) | 24 | (72.7) | 3 | (50.0) | 21 | (77.8) |
| Injury | 54 | (77.1) | 17 | (68.0) | 37 | (82.2) | 28 | (75.7) | 12 | (63.2) | 16 | (88.9) | 26 | (78.8) | 5 | (83.3) | 21 | (77.8) |
| Acute injury | 31 | (44.3) | 7 | (28.0) | 24 | (53.3) | 16 | (43.2) | 6 | (31.6) | 10 | (55.6) | 15 | (45.5) | 1 | (16.7) | 14 | (51.9) |
| Overuse injury | 37 | (52.9) | 13 | (52.0) | 24 | (53.3) | 19 | (51.4) | 9 | (47.4) | 10 | (55.6) | 18 | (54.5) | 4 | (66.7) | 14 | (51.9) |
Average weekly prevalence (with 95% confidence intervals) during the 30-week observation period of all health problems and substantial health problems reported, as well as for subcategories of illness, acute and overuse injury in each subgroup of sex and disciplines.
| Athletes [n (%)] | 70 (100.0) | 25 (35.7) | 45 (64.3) | 37 (52.9) | 19 (27.1) | 18 (25.7) | 33 (47.1) | 6 (8.6) | 27 (38.6) |
| Response rate [mean (SD)] | 71.3 (11.6) | 64.4 (12.5) | 75.1 (11.6) | 69.2 (11.6) | 63.0 (13.3) | 75.9 (10.4) | 73.6 (12.5) | 69.0 (15.3) | 74.6 (13.4) |
| All health problems | 27.3 (16.9 to 37.8) | 32.7 (21.7 to 43.7) | 24.7 (14.6 to 34.9) | 25.6 (15.4 to 35.8) | 27.4 (16.9 to 37.8) | 24.2 (14.2 to 34.2) | 29.0 (18.4 to 39.6) | 47.1 (35.4 to 58.8) | 25.2 (15.0 to 13.0) |
| Illness | 6.8 (0.9 to 12.7) | 6.9 (0.9 to 12.8) | 6.8 (0.9 to 12.7) | 5.6 (0.2 to 11.0) | 5.8 (0.3 to 11.2) | 5.6 (0.2 to 11.0) | 8.0 (1.6 to 14.3) | 8.9 (2.2 to 15.5) | 7.6 (1.4 to 13.9) |
| Injury | 20.5 (11.0 to 30.0) | 25.9 (15.6 to 36.1) | 17.9 (8.9 to 26.9) | 20.0 (10.6 to 29.3) | 21.6 (12.0 to 31.3) | 18.6 (9.5 to 27.7) | 21.0 (11.5 to 30.6) | 38.3 (26.9 to 49.7) | 17.5 (8.6 to 26.5) |
| Acute injury | 7.5 (1.3 to 13.7) | 4.3 (−0.5 to 9.0) | 9.0 (2.3 to 15.7) | 7.5 (1.3 to 13.6) | 5.5 (0.1 to 10.8) | 9.3 (2.5 to 16.1) | 7.4 (1.3 to 13.6) | 0.9 (−1.3 to 3.0) | 8.8 (2.2 to 15.5) |
| Overuse injury | 13.0 (5.1 to 20.9) | 21.6 (12.0 to 31.2) | 9.0 (2.3 to 15.6) | 12.5 (4.8 to 20.3) | 16.2 (7.5 to 24.8) | 9.3 (2.5 to 16.1) | 13.6 (5.6 to 21.6) | 37.4 (26.1 to 48.7) | 3.9 (−0.6 to 8.4) |
| Substantial health problems | 10.6 (3.4 to 17.8) | 17.6 (8.7 to 26.6) | 7.4 (1.3 to 13.5) | 11.3 (3.9 to 18.7) | 15.6 (7.1 to 24.1) | 8.0 (1.6 to 14.3) | 9.8 (2.8 to 16.8) | 22.8 (13.0 to 32.6) | 7.0 (1.0 to 13.0) |
| Illness | 2.1 (−1.3 to 5.4) | 2.1 (−1.3 to 5.4) | 2.1 (−1.3 to 5.5) | 2.2 (−1.2 to 5.7) | 1.8 (−1.3 to 5.0) | 2.7 (−1.1 to 6.6) | 1.9 (−1.3 to 5.1) | 2.6 (−1.1 to 6.3) | 1.8 (−1.3 to 4.8) |
| Injury | 8.4 (1.9 to 14.9) | 15.4 (6.9 to 23.8) | 5.1 (0.0 to 10.3) | 9.2 (2.4 to 15.9) | 13.6 (5.5 to 21.6) | 5.6 (0.2 to 11.0) | 7.5 (1.3 to 13.7) | 20.2 (10.8 to 29.6) | 4.8 (−0.2 to 9.8) |
| Acute injury | 3.4 (−0.9 to 7.6) | 2.6 (−1.1 to 6.3) | 3.7 (−0.7 to 8.2) | 3.5 (−0.8 to 7.7) | 3.5 (−0.8 to 7.8) | 3.5 (−0.8 to 7.8) | 3.2 (−0.9 to 7.3) | 0.0 (0.0 to 0.0) | 3.9 (−0.6 to 8.4) |
| Overuse injury | 5.0 (−0.1 to 10.1) | 12.8 (5.0 to 20.7) | 1.4 (−1.4 to 4.2) | 5.7 (0.3 to 11.2) | 10.1 (3.0 to 17.1) | 2.1 (−1.3 to 5.5) | 4.3 (−0.4 to 9.1) | 20.2 (10.8 to 29.6) | 0.9 (−1.3 to 3.1) |
Significant difference between male and female athletes.
Significant difference between endurance and explosive disciplines.
Figure 1Weekly response rates during the 30-week follow-up for (A) all the 70 participants, and for (B) endurance and explosive male and female athletes separately.
Figure 2Weekly prevalence of health problems [all and substantial health problems (A), illnesses (B), acute injuries (C) and overuse injuries (D)] reported during the 30-week follow-up period.
Characteristics of reported illnesses (results are presented in percentage of illnesses per categories of sex and discipline).
| Upper respiratory tract | 73.0 | 81.8 | 69.2 | 73.3 | 86.7 | 60.0 | 72.7 | 71.4 | 73.0 |
| Lower respiratory tract | 9.5 | 4.5 | 11.5 | 6.7 | 6.7 | 6.7 | 11.4 | 0.0 | 13.5 |
| Gastrointestinal | 10.8 | 9.1 | 11.5 | 16.7 | 6.7 | 26.7 | 6.8 | 14.3 | 5.4 |
| Urogenital/Gynecological | 2.7 | 4.5 | 1.9 | 0.0 | 0.0 | 0.0 | 4.5 | 14.3 | 2.7 |
| Neurological | 1.4 | 0.0 | 1.9 | 0.0 | 0.0 | 0.0 | 2.3 | 0.0 | 2.7 |
| Ophtalmological/Otological | 2.7 | 0.0 | 3.8 | 3.3 | 0.0 | 6.7 | 2.3 | 0.0 | 2.7 |
| Minor | 68.9 | 68.2 | 69.2 | 66.7 | 73.3 | 60.0 | 70.5 | 57.1 | 73.0 |
| Moderate | 31.1 | 31.8 | 30.8 | 33.3 | 26.7 | 40.0 | 29.5 | 42.9 | 27.0 |
| Severe | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Characteristics of reported acute and overuse injuries [results are presented in numbers (percentage)].
| Head | 1 | (0.9) | 0 | (0.0) | 0 | (0.0) | 1 | (2.6) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (1.9) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (2.2) | 1 | (5.3) | 0 | (0.0) |
| Trunk | 15 | (12.8) | 1 | (11.1) | 0 | (0.0) | 8 | (21.1) | 6 | (13.0) | 9 | (14.1) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 9 | (23.1) | 6 | (31.6) | 3 | (15.0) | 6 | (11.3) | 1 | (12.5) | 1 | (100.0) | 0 | (0.0) | 5 | (11.1) | 2 | (10.5) | 3 | (11.5) |
| Upper extremity | 9 | (7.7) | 1 | (11.1) | 0 | (0.0) | 3 | (7.9) | 5 | (10.9) | 7 | (10.9) | 1 | (4.0) | 1 | (12.5) | 0 | (0.0) | 6 | (15.4) | 3 | (15.8) | 3 | (15.0) | 2 | (3.8) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 2 | (4.4) | 0 | (0.0) | 2 | (7.7) |
| Pelvic/Hip/Groin | 12 | (10.3) | 1 | (11.1) | 4 | (16.7) | 4 | (10.5) | 3 | (6.5) | 5 | (7.8) | 2 | (8.0) | 1 | (12.5) | 1 | (5.9) | 3 | (7.7) | 2 | (10.5) | 1 | (5.0) | 7 | (13.2) | 3 | (37.5) | 0 | (0.0) | 3 | (42.9) | 4 | (8.9) | 2 | (10.5) | 2 | (7.7) |
| Quadriceps | 5 | (4.3) | 0 | (0.0) | 0 | (0.0) | 3 | (7.9) | 2 | (4.3) | 2 | (3.1) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 2 | (5.1) | 0 | (0.0) | 2 | (10.0) | 3 | (5.7) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 3 | (6.7) | 3 | (15.8) | 0 | (0.0) |
| Hamstrings | 26 | (22.2) | 1 | (11.1) | 2 | (8.3) | 7 | (18.4) | 16 | (34.8) | 14 | (21.9) | 3 | (12.0) | 1 | (12.5) | 2 | (11.8) | 11 | (28.2) | 3 | (15.8) | 8 | (40.0) | 12 | (22.6) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 12 | (26.7) | 4 | (21.1) | 8 | (30.8) |
| Knee | 14 | (12.0) | 2 | (22.2) | 6 | (25.0) | 6 | (15.8) | 0 | (0.0) | 10 | (15.6) | 7 | (28.0) | 2 | (25.0) | 5 | (29.4) | 3 | (7.7) | 3 | (15.8) | 0 | (0.0) | 4 | (7.5) | 1 | (12.5) | 0 | (0.0) | 1 | (14.3) | 3 | (6.7) | 3 | (15.8) | 0 | (0.0) |
| Anterior lower leg | 5 | (4.3) | 0 | (0.0) | 3 | (12.5) | 0 | (0.0) | 2 | (4.3) | 4 | (6.3) | 3 | (12.0) | 0 | (0.0) | 3 | (17.6) | 1 | (2.6) | 0 | (0.0) | 1 | (5.0) | 1 | (1.9) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (2.2) | 0 | (0.0) | 1 | (3.8) |
| Posterior lower leg | 16 | (13.7) | 2 | (22.2) | 3 | (12.5) | 3 | (7.9) | 8 | (17.4) | 5 | (7.8) | 3 | (12.0) | 2 | (25.0) | 1 | (5.9) | 2 | (5.1) | 0 | (0.0) | 2 | (10.0) | 11 | (20.8) | 2 | (25.0) | 0 | (0.0) | 2 | (28.6) | 9 | (20.0) | 3 | (15.8) | 6 | (23.1) |
| Ankle (lateral) | 2 | (1.7) | 0 | (0.0) | 0 | (0.0) | 2 | (5.3) | 0 | (0.0) | 1 | (1.6) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (2.6) | 1 | (5.3) | 0 | (0.0) | 1 | (1.9) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (2.2) | 1 | (5.3) | 0 | (0.0) |
| Foot | 12 | (10.3) | 1 | (11.1) | 6 | (25.0) | 1 | (2.6) | 4 | (8.7) | 7 | (10.9) | 6 | (24.0) | 1 | (12.5) | 5 | (29.4) | 1 | (2.6) | 1 | (5.3) | 0 | (0.0) | 5 | (9.4) | 1 | (12.5) | 0 | (0.0) | 1 | (14.3) | 4 | (8.9) | 0 | (0.0) | 4 | (15.4) |
| Concussion | 1 | (0.9) | 0 | (0.0) | 0 | (0.0) | 1 | (2.6) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (1.9) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (2.2) | 1 | (5.3) | 0 | (0.0) |
| Stress fracture | 2 | (1.7) | 0 | (0.0) | 2 | (8.3) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 2 | (3.8) | 2 | (25.0) | 0 | (0.0) | 2 | (28.6) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) |
| Other bone injuries | 9 | (7.7) | 1 | (11.1) | 3 | (12.5) | 1 | (2.6) | 4 | (8.7) | 5 | (7.8) | 4 | (16.0) | 1 | (12.5) | 3 | (17.6) | 1 | (2.6) | 1 | (5.3) | 0 | (0.0) | 4 | (7.5) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 4 | (8.9) | 0 | (0.0) | 4 | (15.4) |
| Ligmanetous injuries | 9 | (7.7) | 0 | (0.0) | 1 | (4.2) | 7 | (18.4) | 1 | (2.2) | 5 | (7.8) | 1 | (4.0) | 0 | (0.0) | 1 | (5.9) | 4 | (10.3) | 3 | (15.8) | 1 | (5.0) | 4 | (7.5) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 4 | (8.9) | 4 | (21.1) | 0 | (0.0) |
| Meniscus/cartilage | 3 | (2.6) | 0 | (0.0) | 0 | (0.0) | 2 | (5.3) | 1 | (2.2) | 1 | (1.6) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (2.6) | 1 | (5.3) | 0 | (0.0) | 2 | (3.8) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 2 | (4.4) | 1 | (5.3) | 1 | (3.8) |
| Muscle strain/tear | 15 | (12.8) | 4 | (44.4) | 0 | (0.0) | 11 | (28.9) | 0 | (0.0) | 8 | (12.5) | 4 | (16.0) | 4 | (50.0) | 0 | (0.0) | 4 | (10.3) | 4 | (21.1) | 0 | (0.0) | 7 | (13.2) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 7 | (15.6) | 7 | (36.8) | 0 | (0.0) |
| Muscle cramps | 59 | (50.4) | 2 | (22.2) | 8 | (33.3) | 12 | (31.6) | 37 | (80.4) | 30 | (46.9) | 5 | (20.0) | 1 | (12.5) | 4 | (23.5) | 25 | (64.1) | 8 | (42.1) | 17 | (85.0) | 29 | (54.7) | 5 | (62.5) | 1 | (100.0) | 4 | (57.1) | 24 | (53.3) | 4 | (21.1) | 20 | (76.9) |
| Tendinosis/tendinopathy/ aponeurosis | 15 | (12.8) | 1 | (11.1) | 10 | (41.7) | 2 | (5.3) | 2 | (4.3) | 12 | (18.8) | 10 | (40.0) | 1 | (12.5) | 9 | (52.9) | 2 | (5.1) | 1 | (5.3) | 1 | (5.0) | 3 | (5.7) | 1 | (12.5) | 0 | (0.0) | 1 | (14.3) | 2 | (4.4) | 1 | (5.3) | 1 | (3.8) |
| Arthritis/synovitis/bursitis/ impignement | 4 | (3.4) | 1 | (11.1) | 0 | (0.0) | 2 | (5.3) | 1 | (2.2) | 3 | (4.7) | 1 | (4.0) | 1 | (12.5) | 0 | (0.0) | 2 | (5.1) | 1 | (5.3) | 1 | (5.0) | 1 | (1.9) | 0 | (0.0) | 0 | (0.0) | 0 | (0.0) | 1 | (2.2) | 1 | (5.3) | 0 | (0.0) |
| Minor | 62 | (53.0) | 5 | (55.6) | 14 | (58.3) | 17 | (44.7) | 26 | (56.5) | 34 | (53.1) | 15 | (60.0) | 4 | (50.0) | 11 | (64.7) | 19 | (48.7) | 8 | (42.1) | 11 | (55.0) | 28 | (52.8) | 4 | (50.0) | 1 | (100.0) | 3 | (42.9) | 24 | (53.3) | 9 | (47.4) | 15 | (57.7) |
| Moderate | 36 | (30.8) | 1 | (11.1) | 6 | (25.0) | 12 | (31.6) | 17 | (37.0) | 21 | (32.8) | 6 | (24.0) | 1 | (12.5) | 5 | (29.4) | 15 | (38.5) | 8 | (42.1) | 7 | (35.0) | 15 | (28.3) | 1 | (12.5) | 0 | (0.0) | 1 | (14.3) | 14 | (31.1) | 4 | (21.1) | 10 | (38.5) |
| Severe | 19 | (16.2) | 3 | (33.3) | 4 | (16.7) | 9 | (23.7) | 3 | (6.5) | 9 | (14.1) | 4 | (16.0) | 3 | (37.5) | 1 | (5.9) | 5 | (12.8) | 3 | (15.8) | 2 | (10.0) | 10 | (18.9) | 3 | (37.5) | 0 | (0.0) | 3 | (42.9) | 7 | (15.6) | 6 | (31.6) | 1 | (3.8) |
For all athletes, there was a significant difference between acute and overuse injuries in the distribution of injury type (Chi2 = 40.9; p < 0.0001), but not for location and type.